NANOPARTICLE DELIVERY OF THE HISTONE DEACETYLASE INHIBITOR PXD101 FACILITATES BLADDER CANCER CELL UPTAKE AND CYTOTOXICITY

被引：0
|
作者：
Kaimakliotis, Hristos Z.
Martin, Darryl T.
Hoimes, Christopher J.
Cheng, Christopher C.
Liu, Jingchun
Kelly, Wm. Kevin
Tew, Gregory N.
Saltzman, W. Mark
Weiss, Robert M.
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.1180
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1358
引用
收藏
页码：E542 / E542
页数：1
相关论文
共 50 条
  • [31] A simple and sensitive high-performance liquid chromatographic method for quantification of PXD101, a histone deacetylase inhibitor in human plasma
    Zhang, Ningning
    Goh, Boon Cher
    Khoo, Yok Moi
    Yeo, Winnie
    Lee, How Sung
    THERAPEUTIC DRUG MONITORING, 2007, 29 (02) : 231 - 235
  • [32] Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma
    Ramalingam, Suresh S.
    Belani, Chandra. P.
    Ruel, Christopher
    Frankel, Paul
    Gitlitz, Barbara
    Koczywas, Marianna
    Espinoza-Delgado, Igor
    Gandara, David
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 97 - 101
  • [33] Activity of the histone deacetylase (HDAC) inhibitor PXD101 in preclinical studies and in a phase I study in patients with advanced haematological tumors.
    Gimsing, P
    Wu, F
    Qian, XZ
    Jeffers, M
    Knudsen, L
    Sehested, M
    Lichenstein, HS
    BLOOD, 2005, 106 (11) : 932A - 933A
  • [34] Gene expression screen in cell panel selected for varying sensitivity towards the histone deacetylase inhibitor (HDACi) PXD101 reveals potential predictors of HDACi sensitivity
    Dejligbjerg, Marielle
    Christensen, Ib Jarle
    Grauslund, Morten
    Jensen, Peter B.
    Sehested, Maxwell
    APMIS, 2007, 115 (03) : 287 - 287
  • [35] Nuclear factor-κB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101
    Duan, Jianming
    Friedman, Jay
    Nottingham, Liesi
    Chen, Zhong
    Ara, Gulshan
    Van Waes, Carter
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) : 37 - 50
  • [36] A phase 1 pharmacokinetic (PK) and pharmacodynamic (PD) study of the histone deacetylase (HDAC) inhibitor PXD101 in patients (pts) with advanced solid tumours.
    Steele, N
    Vidal, L
    Plumb, J
    Attard, G
    Rasmussen, A
    Buhl-Jensen, P
    Brown, R
    Blagden, S
    Evans, J
    de Bono, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 200S - 200S
  • [37] The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage
    Feng, Rentian
    Oton, Ana
    Mapara, Markus Y.
    Anderson, Guelsuem
    Belani, Chandra
    Lentzsch, Suzanne
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (03) : 385 - 397
  • [38] Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 Synergizes With the Histone Deacetylase Inhibitor PXD101 in Induction of Death of Anaplastic Thyroid Carcinoma Cells
    Kim, Si Hyoung
    Kang, Jun Goo
    Kim, Chul Sik
    Ihm, Sung-Hee
    Choi, Moon Gi
    Yoo, Hyung Joon
    Lee, Seong Jin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : E253 - E261
  • [39] Combination of the proteasome inhibitor bortezomib and a histone deacetylase inhibitor PXD101 results in synergistic inhibition of osteoclastogenesis and significantly stronger inhibition of multiple myeloma growth in vitro and in vivo.
    Feng, Rentian
    Oton, Ana B.
    Patrene, Kenneth
    Anderson, Gulsum
    Mapara, Markus Y.
    Belani, Chandra
    Roodman, David
    Lentzsch, Suzanne
    BLOOD, 2006, 108 (11) : 153A - 154A
  • [40] Effects of a novel histone deacetylase inhibitor, PXD101, when used as monotherapy or in combination with bortezomib on tumor growth in mouse models of human multiple myeloma.
    Campbell, Richard A.
    Sanchez, Eric
    Chen, Haiming
    Turker, Lauren
    Trac, Olivia
    Li, Mingjie
    Shalitin, Dror
    Gordon, Melinda S.
    Pang, Shen
    Bonavida, Benjamin
    Said, Jonathan
    Jeffers, Michael
    Qian, Xiaozhong
    Lichenstein, Henri S.
    Berenson, James R.
    BLOOD, 2006, 108 (11) : 993A - 993A
12345